The sun health research institute brain donation program: Description and experience, 1987-2007

Cell and Tissue Banking

Volumn 9, Issue 3, 2008, Pages 229-245

  Beach, Thomas G ^a   Sue, Lucia I ^a   Walker, Douglas G ^a   Roher, Alex E ^a   Lue, LihFen ^a   Vedders, Linda ^a   Connor, Donald J ^a   Sabbagh, Marwan N ^a   Rogers, Joseph ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Autopsy; Brain banking; Cerebrospinal fluid; Neuropathology; pH; Postmortem; Postmortem interval; RNA; Tissue banking

Indexed keywords

DNA; RNA;

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN REGION; BRAIN TISSUE; CEREBROSPINAL FLUID PH; CLINICAL EVALUATION; COMMUNITY; DEGENERATIVE DISEASE; DIAGNOSTIC PROCEDURE; FROZEN SECTION; FUNDING; GENOTYPE; HEALTH CARE FACILITY; HEALTH PROGRAM; HUMAN; NEUROPATHOLOGY; ORGAN DONOR; POPULATION RESEARCH; PRIORITY JOURNAL; UNITED STATES;

ACADEMIES AND INSTITUTES; ARIZONA; BRAIN; DATABASES, NUCLEIC ACID; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; POSTMORTEM CHANGES; TISSUE AND ORGAN PROCUREMENT; TISSUE BANKS; TISSUE DONORS; TISSUE PRESERVATION; TISSUE SURVIVAL;

EID: 48449088739     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-008-9067-2     Document Type: Article

References (58)

1. Adachi T, Inanami O, Sato A (1992) Nitric oxide (NO) is involved in increased cerebral cortical blood flow following stimulation of the nucleus basalis of Meynert in anesthetized rats. Neurosci Lett 139:201-204
2. Beach TG, Tago H, Nagai T, Kimura H, McGeer PL, McGeer EG (1987) Perfusion-fixation of the human brain for immunohistochemistry: comparison with immersion-fixation. J Neurosci Methods 19:183-192
3. Beach TG, Sue L, Scott S, Layne K, Newell A, Walker D, Baker M, Sahara N, Yen SH, Hutton M, Caselli R, Adler C, Connor D, Sabbagh M (2003) Hippocampal sclerosis dementia with tauopathy. Brain Pathol 13:263-278
4. Beach TG, Walker DG, Sue LI, Newell A, Adler CC, Joyce JN (2004) Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers. J Neuropathol Exp Neurol 63:329-337
5. Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1:213-216
6. Castano EM, Roher AE, Esh CL, Kokjohn TA, Beach T (2006) Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects. Neurol Res 28:155-163
7. Catts VS, Catts SV, Fernandez HR, Taylor JM, Coulson EJ, Lutze-Mann LH (2005) A microarray study of post-mortem mRNA degradation in mouse brain tissue. Brain Res Mol Brain Res 138:164-177
8. Cummings TJ, Strum JC, Yoon LW, Szymanski MH, Hulette CM (2001) Recovery and expression of messenger RNA from postmortem human brain tissue. Mod Pathol 14:1157-1161
9. Dickson DW (2005) Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases. Acta Neuropathol (Berl) 109(1):14-24
10. Ellis RJ, Jan K, Kawas C, Koller WC, Lyons KE, Jeste DV, Hansen LA, Thal LJ (1998) Diagnostic validity of the dementia questionnaire for Alzheimer disease. Arch Neurol 55:360-365
11. Ferrer I, Santpere G, Arzberger T, Bell J, Blanco R, Boluda S, Budka H, Carmona M, Giaccone G, Krebs B, Limido L, Parchi P, Puig B, Strammiello R, Strobel T, Kretzschmar H (2007) Brain protein preservation largely depends on the postmortem storage temperature: Implications for study of proteins in human neurologic diseases and management of brain banks: A BrainNet Europe Study. J Neuropathol Exp Neurol 66:35-46
12. Gartner U, Janke C, Holzer M, Vanmechelen E, Arendt T (1998) Postmortem changes in the phosphorylation state of tau-protein in the rat brain. Neurobiol Aging 19:535-543
13. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B (1988) The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96:857-881
14. Gustavsson JP, Asberg M, Schalling D (1997) The healthy control subject in psychiatric research: Impulsiveness and volunteer bias. Acta Psychiatr Scand 96:325-328
15. Hardy JA, Wester P, Winblad B, Gezelius C, Bring G, Eriksson A (1985) The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue. J Neural Transm 61:253-264
16. Harrison PJ, Heath PR, Eastwood SL, Burnet PW, McDonald B, Pearson RC (1995) The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: Selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 200:151-154
17. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545-548
18. Hynd MR, Lewohl JM, Scott HL, Dodd PR (2003) Biochemical and molecular studies using human autopsy brain tissue. J Neurochem 85:543-562
19. Johanneson B, Steinsson K, Lindqvist AK, Kristjansdottir H, Grondal G, Sandino S, Tjernstrom F, Sturfelt G, Granados-Arriola J, Alcocer-Varela J, Lundberg I, Jonasson I, Truedsson L, Svenungsson E, Klareskog L, Alarcon-Segovia D, Gyllensten UB, Alarcon-Riquelme ME (1999) A comparison of genome-scans performed in multicase families with systemic lupus erythematosus from different population groups. J Autoimmun 13:137-141
20. Johnson SA, Morgan DG, Finch CE (1986) Extensive postmortem stability of RNA from rat and human brain. J Neurosci Res 16:267-280
21. Johnston NL, Cervenak J, Shore AD, Torrey EF, Yolken RH (1997) Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. Stanley Neuropathology Consortium. J Neurosci Methods 77:83-92
22. Karkela JT (1993) Critical evaluation of postmortem changes in human autopsy cisternal fluid. Enzymes, electrolytes, acid-base balance, glucose and glycolysis, free amino acids and ammonia. Correlation to total brain ischemia. J Forensic Sci 38:603-616
23. Kingsbury AE, Foster OJ, Nisbet AP, Cairns N, Bray L, Eve DJ, Lees AJ, Marsden CD (1995) Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res 28:311-318
24. Kuo YM, Emmerling MR, Bisgaier CL, Essenburg AD, Lampert HC, Drumm D, Roher AE (1998) Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels. Biochem Biophys Res Commun 252:711-715
25. Kuo YM, Emmerling MR, Lampert HC, Hempelman SR, Kokjohn TA, Woods AS, Cotter RJ, Roher AE (1999) High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease. Biochem Biophys Res Commun 257:787-791
26. Kuo YM, Kokjohn TA, Kalback W, Luehrs D, Galasko DR, Chevallier N, Koo EH, Emmerling MR, Roher AE (2000a) Amyloid-beta peptides interact with plasma proteins and erythrocytes: Implications for their quantitation in plasma. Biochem Biophys Res Commun 268:750-756
27. Kuo YM, Kokjohn TA, Watson MD, Woods AS, Cotter RJ, Sue LI, Kalback WM, Emmerling MR, Beach TG, Roher AE (2000b) Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism. Am J Pathol 156:797-805
28. Leong AS, Gilham PN (1989) The effects of progressive formaldehyde fixation on the preservation of tissue antigens. Pathology 21:266-268
29. Li JZ, Vawter MP, Walsh DM, Tomita H, Evans SJ, Choudary PV, Lopez JF, Avelar A, Shokoohi V, Chung T, Mesarwi O, Jones EG, Watson SJ, Akil H, Bunney WE Jr, Myers RM (2004) Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet 13:609-616
30. Lim A, Kukull W, Nochlin D, Leverenz J, McCormick W, Bowen J, Thompson J, Peskind ER, Raskind M (1999) Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series. J Am Geriatr Soc 47:564-569
31. Lio D, Pes GM, Carru C, Listi F, Ferlazzo V, Candore G, Colonna-Romano G, Ferrucci L, Deiana L, Baggio G, Franceschi C, Caruso C (2003) Association between the HLA-DR alleles and longevity: A study in Sardinian population. Exp Gerontol 38:313-317
32. Ludes B, Pfitzinger H, Mangin P (1993) DNA fingerprinting from tissues after variable postmortem periods. J Forensic Sci 38:686-690
33. Lue LF, Walker DG (2002) Modeling Alzheimer's disease immune therapy mechanisms: Interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide. J Neurosci Res 70:599-610
34. Lue LF, Brachova L, Walker DG, Rogers J (1996) Characterization of glial cultures from rapid autopsies of Alzheimer's and control patients. Neurobiol Aging 17:421-429
35. Mandel FS, Weiner M, Kaplan S, Pelcovitz D, Labruna V (2000) An examination of bias in volunteer subject selection: Findings from an in-depth child abuse study. J Trauma Stress 13:77-88
36. Mathews CA, Reus VI, Bejarano J, Escamilla MA, Fournier E, Herrera LD, Lowe TL, McInnes LA, Molina J, Ophoff RA, Raventos H, Sandkuijl LA, Service SK, Spesny M, Leon PE, Freimer NB (2004) Genetic studies of neuropsychiatric disorders in Costa Rica: A model for the use of isolated populations. Psychiatr Genet 14:13-23
37. McGeer PL, McGeer EG (1976) Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea. J Neurochem 26:65-76
38. Morrison-Bogorad M, Zimmerman AL, Pardue S (1995) Heat-shock 70 messenger RNA levels in human brain: Correlation with agonal fever. J Neurochem 64:235-246
39. Palmer AM, Lowe SL, Francis PT, Bowen DM (1988) Are post-mortem biochemical studies of human brain worthwhile? Biochem Soc Trans 16:472-475
40. Pardue S, Zimmerman AL, Morrison-Bogorad M (1994) Selective postmortem degradation of inducible heat shock protein 70 (hsp70) mRNAs in rat brain. Cell Mol Neurobiol 14:341-357
41. Perry EK, Perry RH, Tomlinson BE (1982) The influence of agonal status on some neurochemical activities of postmortem human brain tissue. Neurosci Lett 29:303-307
42. Peschken CA, Esdaile JM (1999) Rheumatic diseases in North America's indigenous peoples. Semin Arthritis Rheum 28:368-391
43. Pollard K, Lunny D, Holgate CS, Jackson P, Bird CC (1987) Fixation, processing, and immunochemical reagent effects on preservation of T-lymphocyte surface membrane antigens in paraffin-embedded tissue. J Histochem Cytochem 35:1329-1338
44. Preece P, Cairns NJ (2003) Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. Brain Res Mol Brain Res 118:60-71
45. Ravid R, Van Zwieten EJ, Swaab DF (1992) Brain banking and the human hypothalamus-factors to match for, pitfalls and potentials. Prog Brain Res 93:83-95
46. Rogers J, Lue LF, Walker DG, Yan SD, Stern D, Strohmeyer R, Kovelowski CJ (2002) Elucidating molecular mechanisms of Alzheimer's disease in microglial cultures. Ernst Schering Res Found Workshop, pp 25-44
47. Rogers J, Li R, Mastroeni D, Grover A, Leonard B, Ahern G, Cao P, Kolody H, Vedders L, Kolb WP, Sabbagh M (2006) Peripheral clearance of amyloid beta peptide by complement C3-dependent adherence to erythrocytes. Neurobiol Aging 27:1733-1739
48. Roher AE, Kuo YM, Esh C, Knebel C, Weiss N, Kalback W, Luehrs DC, Childress JL, Beach TG, Weller RO, Kokjohn TA (2003) Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol Med 9:112-122
49. Sofuoglu M, Dudish-Poulsen S, Nicodemus KK, Babb DA, Hatsukami DK (2000) Characteristics of research volunteers for inpatient cocaine studies: focus on selection bias. Addict Behav 25:785-790
50. Spokes EG (1979) An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human post-mortem brain tissue. Brain 102:333-346
51. Spokes EG, Koch DJ (1978) Post-mortem stability of dopamine, glutamate decarboxylase and choline acetyltransferase in the mouse brain under conditions simulating the handling of human autopsy material. J Neurochem 31:381-383
52. Stan AD, Ghose S, Gao XM, Roberts RC, Lewis-Amezcua K, Hatanpaa KJ, Tamminga CA (2006) Human postmortem tissue: What quality markers matter? Brain Res 1123:1-11
53. Tomita H, Vawter MP, Walsh DM, Evans SJ, Choudary PV, Li J, Overman KM, Atz ME, Myers RM, Jones EG, Watson SJ, Akil H, Bunney WE Jr (2004) Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry 55:346-352
54. Vanderburg CR, Pfanni R, Tian D, Kiehl T-R, Hsi T, Hedley-Whyte ET, Frosch MP (2005) Factors influencing postmortem RNA integrity in human brain. J Neuropathol Exp Neurol 64:443-443
55. Vonsattel JP, Aizawa H, Ge P, DiFiglia M, McKee AC, MacDonald M, Gusella JF, Landwehrmeyer GB, Bird ED, Richardson EP Jr (1995) An improved approach to prepare human brains for research. J Neuropathol Exp Neurol 54:42-56
56. Walker DG, Lue LF (2005) Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases. J Neurosci Res 81:412-425
57. West MJ (1999) Stereological methods for estimating the total number of neurons and synapses: Issues of precision and bias. Trends Neurosci 22:51-61
58. Yates CM, Butterworth J, Tennant MC, Gordon A (1990) Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J Neurochem 55:1624-1630